首页 > 最新文献

Journal of critical care最新文献

英文 中文
Therapeutic plasma exchange: A promising adjunctive treatment for tuberculosis-induced Hemophagocytic Lymphohistiocytosis? 治疗性血浆置换:治疗性血浆置换:结核病诱发的嗜血细胞淋巴组织细胞增多症的一种前景看好的辅助治疗方法?
IF 3.2 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-07-26 DOI: 10.1016/j.jcrc.2024.154888
Muhammad Ahmad, Muneeza Ijaz, Ali Israr Ahmed, Rukhsar Aftab
{"title":"Therapeutic plasma exchange: A promising adjunctive treatment for tuberculosis-induced Hemophagocytic Lymphohistiocytosis?","authors":"Muhammad Ahmad, Muneeza Ijaz, Ali Israr Ahmed, Rukhsar Aftab","doi":"10.1016/j.jcrc.2024.154888","DOIUrl":"10.1016/j.jcrc.2024.154888","url":null,"abstract":"","PeriodicalId":15451,"journal":{"name":"Journal of critical care","volume":"84 ","pages":"Article 154888"},"PeriodicalIF":3.2,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141788214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine learning for predicting mortality in adult critically ill patients with Sepsis: A systematic review 预测败血症成人重症患者死亡率的机器学习:系统综述。
IF 3.2 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-07-25 DOI: 10.1016/j.jcrc.2024.154889
Nasrin Nikravangolsefid , Swetha Reddy , Hong Hieu Truong , Mariam Charkviani , Jacob Ninan , Larry J. Prokop , Supawadee Suppadungsuk , Waryaam Singh , Kianoush B. Kashani , Juan Pablo Domecq Garces

Introduction: Various Machine Learning (ML) models have been used to predict sepsis-associated mortality. We conducted a systematic review to evaluate the methodologies employed in studies to predict mortality among patients with sepsis.

Methods: Following a pre-established protocol registered at the International Prospective Register of Systematic Reviews, we performed a comprehensive search of databases from inception to February 2024. We included peer-reviewed articles reporting predicting mortality in critically ill adult patients with sepsis.

Results: Among the 1822 articles, 31 were included, involving 1,477,200 adult patients with sepsis. Nineteen studies had a high risk of bias. Among the diverse ML models, Logistic regression and eXtreme Gradient Boosting were the most frequently used, in 22 and 16 studies, respectively. Nine studies performed internal and external validation. Compared with conventional scoring systems such as SOFA, the ML models showed slightly higher performance in predicting mortality (AUROC ranges: 0.62–0.90 vs. 0.47–0.86).

Conclusions: ML models demonstrate a modest improvement in predicting sepsis-associated mortality. The certainty of these findings remains low due to the high risk of bias and significant heterogeneity. Studies should include comprehensive methodological details on calibration and hyperparameter selection, adopt a standardized definition of sepsis, and conduct multicenter prospective designs along with external validations.

简介:各种机器学习(ML)模型已被用于预测脓毒症相关死亡率。我们进行了一项系统性综述,以评估预测脓毒症患者死亡率的研究中所采用的方法:按照在国际系统综述前瞻性注册中心(International Prospective Register of Systematic Reviews)注册的预设方案,我们对从开始到 2024 年 2 月的数据库进行了全面检索。结果:在 1822 篇文章中,有 31 篇是关于脓毒症成人重症患者死亡率预测的:在 1822 篇文章中,有 31 篇被纳入,涉及 1477200 名脓毒症成人患者。有 19 项研究存在高偏倚风险。在各种 ML 模型中,逻辑回归(Logistic regression)和梯度提升(eXtreme Gradient Boosting)是最常用的模型,分别在 22 项和 16 项研究中使用。有 9 项研究进行了内部和外部验证。与 SOFA 等传统评分系统相比,ML 模型在预测死亡率方面的表现略高(AUROC 范围:0.62-0.90 vs. 0.47-0.86):结论:ML 模型在预测脓毒症相关死亡率方面略有改善。结论:ML 模型在预测脓毒症相关死亡率方面有一定的改善,但由于偏倚风险较高且存在显著的异质性,这些研究结果的确定性仍然较低。研究应包括有关校准和超参数选择的全面方法细节,采用脓毒症的标准化定义,并进行多中心前瞻性设计和外部验证。
{"title":"Machine learning for predicting mortality in adult critically ill patients with Sepsis: A systematic review","authors":"Nasrin Nikravangolsefid ,&nbsp;Swetha Reddy ,&nbsp;Hong Hieu Truong ,&nbsp;Mariam Charkviani ,&nbsp;Jacob Ninan ,&nbsp;Larry J. Prokop ,&nbsp;Supawadee Suppadungsuk ,&nbsp;Waryaam Singh ,&nbsp;Kianoush B. Kashani ,&nbsp;Juan Pablo Domecq Garces","doi":"10.1016/j.jcrc.2024.154889","DOIUrl":"10.1016/j.jcrc.2024.154889","url":null,"abstract":"<div><p>Introduction: Various Machine Learning (ML) models have been used to predict sepsis-associated mortality. We conducted a systematic review to evaluate the methodologies employed in studies to predict mortality among patients with sepsis.</p><p>Methods: Following a pre-established protocol registered at the International Prospective Register of Systematic Reviews, we performed a comprehensive search of databases from inception to February 2024. We included peer-reviewed articles reporting predicting mortality in critically ill adult patients with sepsis.</p><p>Results: Among the 1822 articles, 31 were included, involving 1,477,200 adult patients with sepsis. Nineteen studies had a high risk of bias. Among the diverse ML models, Logistic regression and eXtreme Gradient Boosting were the most frequently used, in 22 and 16 studies, respectively. Nine studies performed internal and external validation. Compared with conventional scoring systems such as SOFA, the ML models showed slightly higher performance in predicting mortality (AUROC ranges: 0.62–0.90 vs. 0.47–0.86).</p><p>Conclusions: ML models demonstrate a modest improvement in predicting sepsis-associated mortality. The certainty of these findings remains low due to the high risk of bias and significant heterogeneity. Studies should include comprehensive methodological details on calibration and hyperparameter selection, adopt a standardized definition of sepsis, and conduct multicenter prospective designs along with external validations.</p></div>","PeriodicalId":15451,"journal":{"name":"Journal of critical care","volume":"84 ","pages":"Article 154889"},"PeriodicalIF":3.2,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141766159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluid infusion prior to intubation or anesthesia: A meta-analysis of randomized controlled trials 插管或麻醉前输液:随机对照试验荟萃分析。
IF 3.2 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-07-24 DOI: 10.1016/j.jcrc.2024.154881
Zhenfeng Lu , Jingsheng Guo , Aiping Zhang , Lin Song , Haibin Ni

Background

The results of current randomized controlled trials (RCTs) vary regarding the effectiveness of rehydration prior to anesthesia induction. Our objective was to determine the effectiveness of pre-induction rehydration in patients undergoing tracheal intubation or surgical procedures.

Methods

This meta-analysis followed PRISMA guidelines and was registered in the INPLASY database (registration number: INPLASY2022100099). Two reviewers independently searched PubMed, Embase, The Cochrane Database of Systematic Reviews, and Clinical Trials databases until October 2022, without any restrictions on date. Any randomized controlled trial investigating the administration of intravenous fluids to patients undergoing tracheal intubation or pre-surgical anesthesia induction was considered eligible. Exclusion criteria were applied to exclude certain literature. Data were analyzed using RevMan (5.4.1) software after independent extraction. The primary objective of this study was to determine if intravenous rehydration could reduce the occurrence of hypotensive events and the use of vasoactive drugs following anesthesia induction.

Results

This meta-analysis included seven studies with a total of 2850 patients, including 1430 patients who received rehydration and 1420 control patients. Patients who received early rehydration had a lower incidence of hypotensive events compared to those who did not (RR 0.78, 95% CI 0.66–0.92, P = 0.004). No heterogeneity was observed (p = 0.31, I2 = 16%). However, subgroup analysis showed that rehydration before tracheal intubation did not reduce hypotensive events in critically ill patients (RR 0.99, 95% CI 0.61–1.60, P = 0.96). There were no significant differences in the use of vasoactive medications between the two study groups (RR 0.96, 95% CI 0.80–1.16, P = 0.69). No heterogeneity was observed (p = 0.26, I2 = 23%). The funnel plot indicated no evidence of publication bias.

Conclusions

Pre-induction rehydration can reduce the occurrence of hypotensive events, but only in pre-surgical patients, and does not decrease the use of vasoactive medications.

背景:关于麻醉诱导前补液的效果,目前的随机对照试验(RCT)结果各不相同。我们的目的是确定气管插管或外科手术患者诱导前补液的有效性:该荟萃分析遵循 PRISMA 指南,并在 INPLASY 数据库中注册(注册号:INPLASY2022100099)。两位审稿人独立检索了 PubMed、Embase、The Cochrane Database of Systematic Reviews 和 Clinical Trials 数据库,检索时间截止到 2022 年 10 月,没有任何日期限制。符合条件的随机对照试验均涉及对接受气管插管或手术前麻醉诱导的患者进行静脉输液的研究。排除标准适用于排除某些文献。数据经独立提取后使用RevMan(5.4.1)软件进行分析。本研究的主要目的是确定静脉补液是否能减少麻醉诱导后低血压事件的发生和血管活性药物的使用:这项荟萃分析包括七项研究,共涉及 2850 名患者,其中 1430 名患者接受了补液治疗,1420 名患者接受了对照治疗。与未接受补液的患者相比,接受早期补液的患者发生低血压事件的几率较低(RR 0.78,95% CI 0.66-0.92,P = 0.004)。未观察到异质性(P = 0.31,I2 = 16%)。然而,亚组分析显示,气管插管前补液并不能减少重症患者的低血压事件(RR 0.99,95% CI 0.61-1.60,P = 0.96)。两个研究组在使用血管活性药物方面没有明显差异(RR 0.96,95% CI 0.80-1.16,P = 0.69)。未观察到异质性(P = 0.26,I2 = 23%)。漏斗图显示没有证据表明存在发表偏倚:诱导前补液可减少低血压事件的发生,但仅限于手术前患者,且不会减少血管活性药物的使用。
{"title":"Fluid infusion prior to intubation or anesthesia: A meta-analysis of randomized controlled trials","authors":"Zhenfeng Lu ,&nbsp;Jingsheng Guo ,&nbsp;Aiping Zhang ,&nbsp;Lin Song ,&nbsp;Haibin Ni","doi":"10.1016/j.jcrc.2024.154881","DOIUrl":"10.1016/j.jcrc.2024.154881","url":null,"abstract":"<div><h3>Background</h3><p>The results of current randomized controlled trials (RCTs) vary regarding the effectiveness of rehydration prior to anesthesia induction. Our objective was to determine the effectiveness of pre-induction rehydration in patients undergoing tracheal intubation or surgical procedures.</p></div><div><h3>Methods</h3><p>This meta-analysis followed PRISMA guidelines and was registered in the INPLASY database (registration number: INPLASY2022100099). Two reviewers independently searched PubMed, Embase, The Cochrane Database of Systematic Reviews, and Clinical Trials databases until October 2022, without any restrictions on date. Any randomized controlled trial investigating the administration of intravenous fluids to patients undergoing tracheal intubation or pre-surgical anesthesia induction was considered eligible. Exclusion criteria were applied to exclude certain literature. Data were analyzed using RevMan (5.4.1) software after independent extraction. The primary objective of this study was to determine if intravenous rehydration could reduce the occurrence of hypotensive events and the use of vasoactive drugs following anesthesia induction.</p></div><div><h3>Results</h3><p>This meta-analysis included seven studies with a total of 2850 patients, including 1430 patients who received rehydration and 1420 control patients. Patients who received early rehydration had a lower incidence of hypotensive events compared to those who did not (RR 0.78, 95% CI 0.66–0.92, <em>P</em> = 0.004). No heterogeneity was observed (<em>p</em> = 0.31, I<sup>2</sup> = 16%). However, subgroup analysis showed that rehydration before tracheal intubation did not reduce hypotensive events in critically ill patients (RR 0.99, 95% CI 0.61–1.60, <em>P</em> = 0.96). There were no significant differences in the use of vasoactive medications between the two study groups (RR 0.96, 95% CI 0.80–1.16, <em>P</em> = 0.69). No heterogeneity was observed (<em>p</em> = 0.26, I<sup>2</sup> = 23%). The funnel plot indicated no evidence of publication bias.</p></div><div><h3>Conclusions</h3><p>Pre-induction rehydration can reduce the occurrence of hypotensive events, but only in pre-surgical patients, and does not decrease the use of vasoactive medications.</p></div>","PeriodicalId":15451,"journal":{"name":"Journal of critical care","volume":"84 ","pages":"Article 154881"},"PeriodicalIF":3.2,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does extracorporeal cardiopulmonary resuscitation improve survival with favorable neurological outcome in out-of-hospital cardiac arrest? A systematic review and meta-analysis 体外心肺复苏能否提高院外心脏骤停患者的存活率并改善神经系统预后?系统回顾和荟萃分析。
IF 3.2 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-07-24 DOI: 10.1016/j.jcrc.2024.154882
Linda Pagura , Enrico Fabris , Serena Rakar , Marco Gabrielli , Enzo Mazzaro , Gianfranco Sinagra , Davide Stolfo

Purpose

Extracorporeal cardiopulmonary resuscitation (E-CPR) may improve survival with favorable neurological outcome in patients with refractory out-of-hospital cardiac arrest (OHCA). Unfortunately, recent results from randomized controlled trials were inconclusive. We performed a meta-analysis to investigate the impact of E-CPR on neurological outcome compared to conventional cardiopulmonary resuscitation (C-CPR).

Methods

A systematic research for articles assessing outcomes of adult patients with OHCA either treated with E-CPR or C-CPR up to April 27, 2023 was performed. Primary outcome was survival with favorable neurological outcome at discharge or 30 days. Overall survival was also assessed.

Results

Eighteen studies were included. E-CPR was associated with better survival with favorable neurological status at discharge or 30 days (14% vs 7%, OR 2.35, 95% CI 1.61–3.43, I2 = 80%, p < 0.001, NNT = 17) than C-CPR. Results were consistent if the analysis was restricted to RCTs. Overall survival to discharge or 30 days was also positively affected by treatment with E-CPR (OR = 1.71, 95% CI = 1.18–2.46, I2 = 81%, p = 0.004, NNT = 11).

Conclusions

In this meta-analysis, E-CPR had a positive effect on survival with favorable neurological outcome and, to a smaller extent, on overall mortality in patients with refractory OHCA.

目的:体外心肺复苏(E-CPR)可提高难治性院外心脏骤停(OHCA)患者的存活率并改善其神经功能预后。遗憾的是,最近的随机对照试验结果尚无定论。我们进行了一项荟萃分析,研究与传统心肺复苏术(C-CPR)相比,E-CPR 对神经功能预后的影响:我们对截至 2023 年 4 月 27 日采用 E-CPR 或 C-CPR 治疗的 OHCA 成人患者的疗效进行了系统研究。主要结果是出院时或 30 天内神经系统结果良好的存活率。同时还评估了总生存率:结果:共纳入了 18 项研究。E-CPR与出院时或30天后神经系统状况良好的存活率相关(14% vs 7%,OR 2.35,95% CI 1.61-3.43,I2 = 80%,P 2 = 81%,P = 0.004,NNT = 11):在这项荟萃分析中,E-CPR 对难治性 OHCA 患者的存活率和良好的神经功能预后有积极影响,对总死亡率的影响较小。
{"title":"Does extracorporeal cardiopulmonary resuscitation improve survival with favorable neurological outcome in out-of-hospital cardiac arrest? A systematic review and meta-analysis","authors":"Linda Pagura ,&nbsp;Enrico Fabris ,&nbsp;Serena Rakar ,&nbsp;Marco Gabrielli ,&nbsp;Enzo Mazzaro ,&nbsp;Gianfranco Sinagra ,&nbsp;Davide Stolfo","doi":"10.1016/j.jcrc.2024.154882","DOIUrl":"10.1016/j.jcrc.2024.154882","url":null,"abstract":"<div><h3>Purpose</h3><p>Extracorporeal cardiopulmonary resuscitation (<em>E</em>-CPR) may improve survival with favorable neurological outcome in patients with refractory out-of-hospital cardiac arrest (OHCA). Unfortunately, recent results from randomized controlled trials were inconclusive. We performed a meta-analysis to investigate the impact of <em>E</em>-CPR on neurological outcome compared to conventional cardiopulmonary resuscitation (C-CPR).</p></div><div><h3>Methods</h3><p>A systematic research for articles assessing outcomes of adult patients with OHCA either treated with <em>E</em>-CPR or C-CPR up to April 27, 2023 was performed. Primary outcome was survival with favorable neurological outcome at discharge or 30 days. Overall survival was also assessed.</p></div><div><h3>Results</h3><p>Eighteen studies were included. <em>E</em>-CPR was associated with better survival with favorable neurological status at discharge or 30 days (14% vs 7%, OR 2.35, 95% CI 1.61–3.43, <em>I</em><sup><em>2</em></sup> = 80%, <em>p</em> &lt; 0.001, NNT = 17) than C-CPR. Results were consistent if the analysis was restricted to RCTs. Overall survival to discharge or 30 days was also positively affected by treatment with <em>E</em>-CPR (OR = 1.71, 95% CI = 1.18–2.46, <em>I</em><sup><em>2</em></sup> = 81%, <em>p</em> = 0.004, NNT = 11).</p></div><div><h3>Conclusions</h3><p>In this meta-analysis, E-CPR had a positive effect on survival with favorable neurological outcome and, to a smaller extent, on overall mortality in patients with refractory OHCA.</p></div>","PeriodicalId":15451,"journal":{"name":"Journal of critical care","volume":"84 ","pages":"Article 154882"},"PeriodicalIF":3.2,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
End-tidal carbon dioxide during spontaneous breathing trial to predict extubation failure: A prospective observational study 预测拔管失败的自主呼吸时潮气末二氧化碳试验:前瞻性观察研究
IF 3.2 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-07-19 DOI: 10.1016/j.jcrc.2024.154870
Faten May , Nicolas de Prost , Keyvan Razazi , Guillaume Carteaux , Armand Mekontso Dessap

Despite advances in weaning protocols, extubation failure (EF) is associated with poor outcomes. Many predictors of EF have been proposed, including hypercapnia at the end of the spontaneous breathing test (SBT). However, performing arterial blood gases at the end of SBT is not routinely recommended, whereas end-tidal carbon dioxide (EtCO2) can be routinely monitored during SBT.

We aimed to evaluate the clinical utility of EtCO2 to predict EF. Patients undergoing planned extubation were eligible. Non-inclusion criteria were tracheostomy and patients extubated after successful T-tube SBT. We recorded clinical data and EtCO2 in 189 patients during a successful one-hour low pressure support SBT.

EtCO2 measured before successful SBT was lower in patients with EF compared to those with successful extubation (27 [24–29] vs 30 [27–47] mmHg, p = 0.02), while EtCO2 measured at five minutes and at the end of the SBT was not different between the two groups (26 [22–28] vs. 29 [28–49] mmHg, p = 0.06 and 26 [26–29] vs. 29 [27–49] mmHg, p = 0.09, respectively). Variables identified by multivariable analysis as independently associated with EF were acute respiratory failure as the cause of intubation and ineffective cough.

Our study suggests that recording EtCO2 during successful SBT appears to have limited predictive value for EF.

尽管断奶方案取得了进步,但拔管失败(EF)仍与不良预后有关。有很多预测 EF 的方法,包括在自主呼吸测试(SBT)结束时出现高碳酸血症。然而,在 SBT 结束时进行动脉血气检测并不是常规建议,而在 SBT 期间可以常规监测潮气末二氧化碳(EtCO2)。计划拔管的患者均符合条件。气管造口术和成功进行 T 型管 SBT 后拔管的患者不在纳入标准之列。我们记录了 189 名患者在成功进行一小时低压支持 SBT 期间的临床数据和 EtCO2。与成功拔管的患者相比,EF 患者在成功进行 SBT 之前测量的 EtCO2 更低(27 [24-29] vs 30 [27-47] mmHg,p = 0.02),而在 5 分钟和 SBT 结束时测量的 EtCO2 在两组之间没有差异(分别为 26 [22-28] vs. 29 [28-49] mmHg,p = 0.06 和 26 [26-29] vs. 29 [27-49] mmHg,p = 0.09)。我们的研究表明,在成功的 SBT 过程中记录 EtCO2 似乎对 EF 的预测价值有限。
{"title":"End-tidal carbon dioxide during spontaneous breathing trial to predict extubation failure: A prospective observational study","authors":"Faten May ,&nbsp;Nicolas de Prost ,&nbsp;Keyvan Razazi ,&nbsp;Guillaume Carteaux ,&nbsp;Armand Mekontso Dessap","doi":"10.1016/j.jcrc.2024.154870","DOIUrl":"10.1016/j.jcrc.2024.154870","url":null,"abstract":"<div><p>Despite advances in weaning protocols, extubation failure (EF) is associated with poor outcomes. Many predictors of EF have been proposed, including hypercapnia at the end of the spontaneous breathing test (SBT). However, performing arterial blood gases at the end of SBT is not routinely recommended, whereas end-tidal carbon dioxide (EtCO2) can be routinely monitored during SBT.</p><p>We aimed to evaluate the clinical utility of EtCO2 to predict EF. Patients undergoing planned extubation were eligible. Non-inclusion criteria were tracheostomy and patients extubated after successful T-tube SBT. We recorded clinical data and EtCO2 in 189 patients during a successful one-hour low pressure support SBT.</p><p>EtCO2 measured before successful SBT was lower in patients with EF compared to those with successful extubation (27 [24–29] vs 30 [27–47] mmHg, <em>p</em> = 0.02), while EtCO2 measured at five minutes and at the end of the SBT was not different between the two groups (26 [22–28] vs. 29 [28–49] mmHg, <em>p</em> = 0.06 and 26 [26–29] vs. 29 [27–49] mmHg, <em>p</em> = 0.09, respectively). Variables identified by multivariable analysis as independently associated with EF were acute respiratory failure as the cause of intubation and ineffective cough.</p><p>Our study suggests that recording EtCO2 during successful SBT appears to have limited predictive value for EF.</p></div>","PeriodicalId":15451,"journal":{"name":"Journal of critical care","volume":"84 ","pages":"Article 154870"},"PeriodicalIF":3.2,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141729223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of second antibiotic dose delays on mortality in patients with septic shock 第二次抗生素剂量延迟与脓毒性休克患者死亡率的关系。
IF 3.2 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-07-18 DOI: 10.1016/j.jcrc.2024.154866
Zenalabdin H. Jabir PharmD, Travis S. Grey PharmD, BCPS, BCCCP, Angela R. Morelli PharmD, BCPS, BCIDP, Brandon D. Nornhold PharmD, Jestin N. Carlson MD, MS, MHA, Diane V. Thompson M.S, Animesh C. Gour MD

Objective

Determine whether a delay in the administration of the second dose of antibiotics is associated with an increased risk of mortality for patients admitted with septic shock.

Design

Retrospective, observational evaluation.

Setting

Regional multicenter evaluation including four institutions in western Pennsylvania.

Patients

A total of 905 patients were included in this study who met the criteria for septic shock. Patients that did not receive a second dose of antibiotics, were transferred from an outside facility, or expected death within six hours of hospital admission were excluded.

Interventions

The frequency of second antibiotic dose administration delay was determined. A delay was defined as a delay greater than or equal to 25% of the antibiotic dosing interval.

Measurements and main results

A delay in second antibiotic dose administration was found in 181 (20%) of patients. Patients with a delay in the administration of second dose antibiotics had a higher mortality rate (35%) than patients without a delay (26%) (p =0.018). Patients with and without a delay in the administration of second-dose antibiotics had similar median 28-day vasopressor free days (median = 26.0, IQR = 2.0). Differences in the distribution of the 28-day vasopressor free days between groups resulted in the achievement of statistical significance (Mann-Whitney U = 57,294.5, z = −2.690, p = 0.006). There was no difference in 28-day ventilator-free days between groups. A delay in the administration of second dose antibiotics led to a longer in-hospital length of stay (9 days vs. 7 days; p = 0.022) and a longer ICU length of stay than patients without a delay (5 days vs. 3 days; p = 0.007).

Conclusions

Delays in second antibiotic dose administration in septic shock patients were present but lower than previous studies. These delays were associated with increased mortality, increased ICU and hospital length of stay.

目的:确定延迟使用第二剂抗生素是否会增加脓毒性休克患者的死亡风险:确定延迟使用第二剂抗生素是否会增加脓毒性休克患者的死亡风险:设计:回顾性观察评估:地区多中心评估,包括宾夕法尼亚州西部的四家机构:本研究共纳入 905 名符合脓毒性休克标准的患者。未接受第二剂抗生素治疗的患者、从外部机构转院的患者或预计在入院后六小时内死亡的患者被排除在外:干预措施:确定延迟使用第二剂抗生素的频率。干预措施:测定第二次抗生素给药延迟的频率,延迟时间大于或等于抗生素给药间隔时间的 25%:181例(20%)患者的第二次抗生素给药延迟。延迟使用第二剂抗生素的患者死亡率(35%)高于未延迟使用抗生素的患者(26%)(P =0.018)。延迟使用第二剂抗生素和未延迟使用第二剂抗生素的患者的 28 天无血管舒张剂天数中位数相似(中位数 = 26.0,IQR = 2.0)。各组间 28 天无血管舒张剂天数的分布差异具有统计学意义(Mann-Whitney U = 57,294.5, z = -2.690, p = 0.006)。组间 28 天无呼吸机天数无差异。与未延迟给药的患者相比,延迟给药的患者住院时间更长(9天 vs. 7天;p = 0.022),入住重症监护室的时间更长(5天 vs. 3天;p = 0.007):结论:脓毒性休克患者第二次使用抗生素的时间存在延迟,但低于以往的研究。这些延迟与死亡率增加、重症监护室和住院时间延长有关。
{"title":"Association of second antibiotic dose delays on mortality in patients with septic shock","authors":"Zenalabdin H. Jabir PharmD,&nbsp;Travis S. Grey PharmD, BCPS, BCCCP,&nbsp;Angela R. Morelli PharmD, BCPS, BCIDP,&nbsp;Brandon D. Nornhold PharmD,&nbsp;Jestin N. Carlson MD, MS, MHA,&nbsp;Diane V. Thompson M.S,&nbsp;Animesh C. Gour MD","doi":"10.1016/j.jcrc.2024.154866","DOIUrl":"10.1016/j.jcrc.2024.154866","url":null,"abstract":"<div><h3>Objective</h3><p>Determine whether a delay in the administration of the second dose of antibiotics is associated with an increased risk of mortality for patients admitted with septic shock.</p></div><div><h3>Design</h3><p>Retrospective, observational evaluation.</p></div><div><h3>Setting</h3><p>Regional multicenter evaluation including four institutions in western Pennsylvania.</p></div><div><h3>Patients</h3><p>A total of 905 patients were included in this study who met the criteria for septic shock. Patients that did not receive a second dose of antibiotics, were transferred from an outside facility, or expected death within six hours of hospital admission were excluded.</p></div><div><h3>Interventions</h3><p>The frequency of second antibiotic dose administration delay was determined. A delay was defined as a delay greater than or equal to 25% of the antibiotic dosing interval.</p></div><div><h3>Measurements and main results</h3><p>A delay in second antibiotic dose administration was found in 181 (20%) of patients. Patients with a delay in the administration of second dose antibiotics had a higher mortality rate (35%) than patients without a delay (26%) (<em>p</em> =0.018). Patients with and without a delay in the administration of second-dose antibiotics had similar median 28-day vasopressor free days (median = 26.0, IQR = 2.0). Differences in the distribution of the 28-day vasopressor free days between groups resulted in the achievement of statistical significance (Mann-Whitney U = 57,294.5, z = −2.690, <em>p</em> = 0.006). There was no difference in 28-day ventilator-free days between groups. A delay in the administration of second dose antibiotics led to a longer in-hospital length of stay (9 days vs. 7 days; <em>p</em> = 0.022) and a longer ICU length of stay than patients without a delay (5 days vs. 3 days; <em>p</em> = 0.007).</p></div><div><h3>Conclusions</h3><p>Delays in second antibiotic dose administration in septic shock patients were present but lower than previous studies. These delays were associated with increased mortality, increased ICU and hospital length of stay.</p></div>","PeriodicalId":15451,"journal":{"name":"Journal of critical care","volume":"84 ","pages":"Article 154866"},"PeriodicalIF":3.2,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0883944124003538/pdfft?md5=208b61c2418aae33e2a924e19172eed6&pid=1-s2.0-S0883944124003538-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141727255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors response: “Major determinants of primary non function from kidney donation after Maastricht II circulatory death: A single center experience” 作者回复:"马斯特里赫特 II 循环死亡后肾脏捐献主要决定因素:一个单一中心的经验"。
IF 3.2 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-07-17 DOI: 10.1016/j.jcrc.2024.154865
Ana Gaspar , Madalena Gama , Gustavo Nobre de Jesus , Sara Querido , Juliana Damas , João Oliveira , Marta Neves , Alice Santana , João Miguel Ribeiro
{"title":"Authors response: “Major determinants of primary non function from kidney donation after Maastricht II circulatory death: A single center experience”","authors":"Ana Gaspar ,&nbsp;Madalena Gama ,&nbsp;Gustavo Nobre de Jesus ,&nbsp;Sara Querido ,&nbsp;Juliana Damas ,&nbsp;João Oliveira ,&nbsp;Marta Neves ,&nbsp;Alice Santana ,&nbsp;João Miguel Ribeiro","doi":"10.1016/j.jcrc.2024.154865","DOIUrl":"10.1016/j.jcrc.2024.154865","url":null,"abstract":"","PeriodicalId":15451,"journal":{"name":"Journal of critical care","volume":"84 ","pages":"Article 154865"},"PeriodicalIF":3.2,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0883944124003526/pdfft?md5=53e96969a2be1fd63d160a7dc60c5d7b&pid=1-s2.0-S0883944124003526-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141723670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of early changes in arterial carbon dioxide with acute brain injury in adult patients with extracorporeal membrane oxygenation: A ten-year retrospective study in a German tertiary care hospital 使用体外膜氧合的成年患者动脉二氧化碳的早期变化与急性脑损伤的关系:德国一家三级医院的十年回顾性研究
IF 3.2 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-07-17 DOI: 10.1016/j.jcrc.2024.154880
Yuanyuan Yu , Iris Lettow , Kevin Roedl , Dominik Jarczak , Hans Pinnschmidt , Hermann Reichenspurner , Alexander M. Bernhardt , Gerold Söffker , Benedikt Schrage , Markus Haar , Theresa Weber , Daniel Frings , Stefan Kluge , Marlene Fischer

Purpose

To assess the association between fluctuations of arterial carbon dioxide early after start of extracorporeal membrane oxygenation (ECMO) with intracranial hemorrhage (ICH) or ischemic stroke (IS).

Materials and methods

This single-center retrospective study included patients who required ECMO for circulatory or respiratory failure between January 2011 and April 2021 and for whom a cerebral computed tomography (cCT) scan was available. Multivariable logistic regression models were fitted to evaluate the association between the relative change of arterial carbon dioxide (RelΔPaCO2) and ICH, IS or a composite of ICH, IS, and mortality.

Results

In 618 patients (venovenous ECMO: n = 295; venoarterial ECMO: n = 323) ICH occurred more frequently in patients with respiratory failure (19.0%) compared with patients with circulatory failure (6.8%). Conversely, the incidence of IS was higher in patients with circulatory failure (19.2%) compared with patients with respiratory failure (4.7%). While patients with ECMO for respiratory failure were more likely to have ICH (OR 3.683 [95% CI: 1.855;7.309], p < 0.001), they had a lower odds for IS (OR 0.360 [95%CI: 0.158;0.820], p = 0.015) compared with patients with circulatory failure. There was no significant association between RelΔPaCO2 and ICH or IS.

Conclusions

Irrespective of the indication for ECMO, we did not find a significant association between the relative change in PaCO2 early after ECMO initiation and acute brain injury. Aside from early PaCO2 decline at cannulation, future studies should address fluctuations of PaCO2 throughout the course of ECMO support and their effect on acute brain injury.

目的评估体外膜肺氧合(ECMO)开始后早期动脉二氧化碳的波动与颅内出血(ICH)或缺血性卒中(IS)之间的关系。材料和方法这项单中心回顾性研究纳入了 2011 年 1 月至 2021 年 4 月间因循环或呼吸衰竭而需要 ECMO 的患者,这些患者均接受了脑计算机断层扫描(cCT)。结果 在 618 名患者中(静脉 ECMO:n = 295;静脉动脉 ECMO:n = 323),呼吸衰竭患者(19.0%)比循环衰竭患者(6.8%)更常发生 ICH。相反,循环衰竭患者的 IS 发生率(19.2%)高于呼吸衰竭患者(4.7%)。虽然因呼吸衰竭而接受 ECMO 的患者更有可能发生 ICH(OR 3.683 [95%CI: 1.855;7.309],p < 0.001),但与循环衰竭患者相比,他们发生 IS 的几率较低(OR 0.360 [95%CI: 0.158;0.820],p = 0.015)。结论无论 ECMO 的适应症如何,我们都没有发现 ECMO 启动后早期 PaCO2 的相对变化与急性脑损伤之间存在明显关联。除了插管时的早期 PaCO2 下降,未来的研究应关注 ECMO 支持过程中的 PaCO2 波动及其对急性脑损伤的影响。
{"title":"Association of early changes in arterial carbon dioxide with acute brain injury in adult patients with extracorporeal membrane oxygenation: A ten-year retrospective study in a German tertiary care hospital","authors":"Yuanyuan Yu ,&nbsp;Iris Lettow ,&nbsp;Kevin Roedl ,&nbsp;Dominik Jarczak ,&nbsp;Hans Pinnschmidt ,&nbsp;Hermann Reichenspurner ,&nbsp;Alexander M. Bernhardt ,&nbsp;Gerold Söffker ,&nbsp;Benedikt Schrage ,&nbsp;Markus Haar ,&nbsp;Theresa Weber ,&nbsp;Daniel Frings ,&nbsp;Stefan Kluge ,&nbsp;Marlene Fischer","doi":"10.1016/j.jcrc.2024.154880","DOIUrl":"10.1016/j.jcrc.2024.154880","url":null,"abstract":"<div><h3>Purpose</h3><p>To assess the association between fluctuations of arterial carbon dioxide early after start of extracorporeal membrane oxygenation (ECMO) with intracranial hemorrhage (ICH) or ischemic stroke (IS).</p></div><div><h3>Materials and methods</h3><p>This single-center retrospective study included patients who required ECMO for circulatory or respiratory failure between January 2011 and April 2021 and for whom a cerebral computed tomography (cCT) scan was available. Multivariable logistic regression models were fitted to evaluate the association between the relative change of arterial carbon dioxide (RelΔPaCO<sub>2</sub>) and ICH, IS or a composite of ICH, IS, and mortality.</p></div><div><h3>Results</h3><p>In 618 patients (venovenous ECMO: <em>n</em> = 295; venoarterial ECMO: <em>n</em> = 323) ICH occurred more frequently in patients with respiratory failure (19.0%) compared with patients with circulatory failure (6.8%). Conversely, the incidence of IS was higher in patients with circulatory failure (19.2%) compared with patients with respiratory failure (4.7%). While patients with ECMO for respiratory failure were more likely to have ICH (OR 3.683 [95% CI: 1.855;7.309], <em>p</em> &lt; 0.001), they had a lower odds for IS (OR 0.360 [95%CI: 0.158;0.820], <em>p</em> = 0.015) compared with patients with circulatory failure. There was no significant association between RelΔPaCO<sub>2</sub> and ICH or IS.</p></div><div><h3>Conclusions</h3><p>Irrespective of the indication for ECMO, we did not find a significant association between the relative change in PaCO<sub>2</sub> early after ECMO initiation and acute brain injury. Aside from early PaCO<sub>2</sub> decline at cannulation, future studies should address fluctuations of PaCO<sub>2</sub> throughout the course of ECMO support and their effect on acute brain injury.</p></div>","PeriodicalId":15451,"journal":{"name":"Journal of critical care","volume":"84 ","pages":"Article 154880"},"PeriodicalIF":3.2,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0883944124003678/pdfft?md5=b32dd72422284b72effb654a1962f737&pid=1-s2.0-S0883944124003678-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141637702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical care management of hantavirus cardiopulmonary syndrome. A narrative review 汉坦病毒心肺综合征的重症监护管理。叙述性综述
IF 3.2 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-07-17 DOI: 10.1016/j.jcrc.2024.154867
Rodrigo Ulloa-Morrison , Nicolas Pavez , Esteban Parra , Rene Lopez , Roberto Mondaca , Paula Fernandez , David Kraunik , Claudia Sanhueza , Sebastian Bravo , Matias Germán Cornu , Eduardo Kattan

Hantaviruses, members of the Bunyaviridae family, can cause two patterns of disease in humans, hantavirus hemorrhagic fever with renal syndrome (HFRS) and cardiopulmonary syndrome (HCPS), being the latter hegemonic on the American continent. Andesvirus is one of the strains that can cause HCPS and is endemic in Chile. Its transmission occurs through direct or indirect contact with infected rodents' urine, saliva, or feces and inhalation of aerosol particles containing the virus. HCPS rapidly evolves into acute but reversible multiorgan dysfunction. The hemodynamic pattern of HCPS is not identical to that of cardiogenic or septic shock, being characterized by hypovolemia, systolic dysfunction, and pulmonary edema secondary to increased permeability. Given the lack of specific effective therapies to treat this viral infection, the focus of treatment lies in the timely provision of intensive care, specifically hemodynamic and respiratory support, which often requires veno-arterial extracorporeal membrane oxygenation (VA-ECMO). This narrative review aims to provide insights into specific ICU management of HCPS based on the available evidence and gathered experience in Chile and South America including perspectives of pathophysiology, organ dysfunction kinetics, timely life support provision, safe patient transportation, and key challenges for the future.

汉坦病毒是布尼亚病毒科(Bunyaviridae)的成员,可在人类中引起两种疾病,即汉坦病毒出血热伴肾综合征(HFRS)和心肺综合征(HCPS),后者在美洲大陆占据主导地位。安第斯病毒是可导致 HCPS 的病毒株之一,在智利流行。其传播途径是直接或间接接触受感染啮齿动物的尿液、唾液或粪便,以及吸入含有病毒的气溶胶颗粒。HCPS 会迅速发展为急性但可逆的多器官功能障碍。HCPS 的血流动力学模式与心源性休克或脓毒性休克不尽相同,其特点是血容量不足、收缩功能障碍和肺水肿(继发于渗透性增加)。由于缺乏治疗这种病毒感染的特效疗法,治疗的重点在于及时提供重症监护,特别是血液动力学和呼吸支持,这通常需要静脉-动脉体外膜肺氧合(VA-ECMO)。这篇叙述性综述旨在根据现有证据和智利及南美地区的经验,从病理生理学、器官功能障碍动力学、及时提供生命支持、安全运送病人以及未来面临的主要挑战等角度,深入探讨重症监护病房对 HCPS 的具体管理。
{"title":"Critical care management of hantavirus cardiopulmonary syndrome. A narrative review","authors":"Rodrigo Ulloa-Morrison ,&nbsp;Nicolas Pavez ,&nbsp;Esteban Parra ,&nbsp;Rene Lopez ,&nbsp;Roberto Mondaca ,&nbsp;Paula Fernandez ,&nbsp;David Kraunik ,&nbsp;Claudia Sanhueza ,&nbsp;Sebastian Bravo ,&nbsp;Matias Germán Cornu ,&nbsp;Eduardo Kattan","doi":"10.1016/j.jcrc.2024.154867","DOIUrl":"10.1016/j.jcrc.2024.154867","url":null,"abstract":"<div><p>Hantaviruses, members of the <em>Bunyaviridae</em> family, can cause two patterns of disease in humans, hantavirus hemorrhagic fever with renal syndrome (HFRS) and cardiopulmonary syndrome (HCPS), being the latter hegemonic on the American continent. <em>Andesvirus</em> is one of the strains that can cause HCPS and is endemic in Chile. Its transmission occurs through direct or indirect contact with infected rodents' urine, saliva, or feces and inhalation of aerosol particles containing the virus. HCPS rapidly evolves into acute but reversible multiorgan dysfunction. The hemodynamic pattern of HCPS is not identical to that of cardiogenic or septic shock, being characterized by hypovolemia, systolic dysfunction, and pulmonary edema secondary to increased permeability. Given the lack of specific effective therapies to treat this viral infection, the focus of treatment lies in the timely provision of intensive care, specifically hemodynamic and respiratory support, which often requires veno-arterial extracorporeal membrane oxygenation (VA-ECMO). This narrative review aims to provide insights into specific ICU management of HCPS based on the available evidence and gathered experience in Chile and South America including perspectives of pathophysiology, organ dysfunction kinetics, timely life support provision, safe patient transportation, and key challenges for the future.</p></div>","PeriodicalId":15451,"journal":{"name":"Journal of critical care","volume":"84 ","pages":"Article 154867"},"PeriodicalIF":3.2,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141637703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indications, results and consequences of electroencephalography in neurocritical care: A retrospective study 神经重症监护中脑电图的适应症、结果和后果:回顾性研究
IF 3.2 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-07-16 DOI: 10.1016/j.jcrc.2024.154861
Wolmet E. Haksteen MD , Gulsum Z. Nasim MD , Marjolein M. Admiraal PhD , Daan C. Velseboer MD PhD , A. Fleur van Rootselaar MD,PhD , Janneke Horn MD PhD

Purpose

Electrocencephalography (EEG) is a tool to assess cerebral cortical activity. We investigated the indications and results of routine EEG recordings in neurocritical care patients and corresponding changes in anti-seizure medication (ASM).

Materials and methods

This was a single-center, retrospective cohort study. We included all adult Intensive Care Unit (ICU) patients with severe acute brain injury who received a routine EEG (30–60 min). Indications, background patterns, presence of rhythmic and periodic patterns, seizures, and adjustments in ASM were documented.

Results

A total of 109 patients were included. The EEGs were performed primarily to investigate the presence of (non-convulsive) status epilepticus ((NC)SE) and/or seizures. A (slowed) continuous background pattern was present in 94%. Low voltage, burst-suppression and suppressed background patterns were found in six patients (5.5%). Seizures were diagnosed in two patients and (NC)SE was diagnosed in five patients (6.4%). Based on the EEG results, ASM was changed in 47 patients (43%). This encompassed discontinuation of ASM in 27 patients (24.8%) and initiation of ASM in 20 patients (18.3%).

Conclusions

All EEGs were performed to investigate the presence of (NC)SE or seizures. A slowed, but continuous background pattern was found in nearly all patients and (NC)SE and seizures were rarely diagnosed. Adjustments in ASM were made in approximately half of the patients.

目的 脑电图(EEG)是评估大脑皮层活动的一种工具。我们调查了神经重症患者常规脑电图记录的适应症和结果,以及抗癫痫药物(ASM)的相应变化。我们纳入了所有接受常规脑电图检查(30-60 分钟)的重症急性脑损伤成人重症监护病房(ICU)患者。研究记录了适应症、背景模式、节律性和周期性模式的存在、癫痫发作以及 ASM 的调整。进行脑电图检查的主要目的是调查是否存在(非惊厥性)癫痫状态((NC)SE)和/或癫痫发作。94%的患者存在(减慢的)连续背景模式。六名患者(5.5%)出现低电压、爆发抑制和抑制背景模式。两名患者被诊断为癫痫发作,五名患者(6.4%)被诊断为(NC)SE。根据脑电图结果,47 名患者(43%)更换了 ASM。结论对所有脑电图进行检查,以确定是否存在 (NC)SE 或癫痫发作。几乎在所有患者中都发现了缓慢但持续的背景模式,很少诊断出(NC)SE 和癫痫发作。约半数患者对 ASM 进行了调整。
{"title":"Indications, results and consequences of electroencephalography in neurocritical care: A retrospective study","authors":"Wolmet E. Haksteen MD ,&nbsp;Gulsum Z. Nasim MD ,&nbsp;Marjolein M. Admiraal PhD ,&nbsp;Daan C. Velseboer MD PhD ,&nbsp;A. Fleur van Rootselaar MD,PhD ,&nbsp;Janneke Horn MD PhD","doi":"10.1016/j.jcrc.2024.154861","DOIUrl":"10.1016/j.jcrc.2024.154861","url":null,"abstract":"<div><h3>Purpose</h3><p>Electrocencephalography (EEG) is a tool to assess cerebral cortical activity. We investigated the indications and results of routine EEG recordings in neurocritical care patients and corresponding changes in anti-seizure medication (ASM).</p></div><div><h3>Materials and methods</h3><p>This was a single-center, retrospective cohort study. We included all adult Intensive Care Unit (ICU) patients with severe acute brain injury who received a routine EEG (30–60 min). Indications, background patterns, presence of rhythmic and periodic patterns, seizures, and adjustments in ASM were documented.</p></div><div><h3>Results</h3><p>A total of 109 patients were included. The EEGs were performed primarily to investigate the presence of (non-convulsive) status epilepticus ((NC)SE) and/or seizures. A (slowed) continuous background pattern was present in 94%. Low voltage, burst-suppression and suppressed background patterns were found in six patients (5.5%). Seizures were diagnosed in two patients and (NC)SE was diagnosed in five patients (6.4%). Based on the EEG results, ASM was changed in 47 patients (43%). This encompassed discontinuation of ASM in 27 patients (24.8%) and initiation of ASM in 20 patients (18.3%).</p></div><div><h3>Conclusions</h3><p>All EEGs were performed to investigate the presence of (NC)SE or seizures. A slowed, but continuous background pattern was found in nearly all patients and (NC)SE and seizures were rarely diagnosed. Adjustments in ASM were made in approximately half of the patients.</p></div>","PeriodicalId":15451,"journal":{"name":"Journal of critical care","volume":"84 ","pages":"Article 154861"},"PeriodicalIF":3.2,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0883944124003484/pdfft?md5=661be283939510011156d2de1c85dcc7&pid=1-s2.0-S0883944124003484-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141630741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of critical care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1